Assume you represent Company A. Your competitor, Company B, has just released a new patented product. You've decided to TPO their patent, as you may release a similar product soon. Company C, another competitor, already has a similar product, and released a statement saying that they "retain prior rights" to the results of their R&D, and that the sale of "a product similar to what they have [...] may constitute an infringement of [their] rights." You've conducted a patent search and have yet to find a patent that matches Compancy C's product. A physical teardown of their products suggest that Company B isn't infringing on your patents but is using public domain knowledge, while Company C's product is likely infringing on your patents. What is your plan?

Gemini 3.5 Flash

Answer: Our plan is to aggressively proceed with the Third-Party Observation (TPO) against Company B using public domain evidence, while preparing to assert our patent rights against Company C to neutralize their threats and secure our freedom to operate.

We maintain our dual-track strategy, as it represents the most effective path to securing Company A's market entry while neutralizing competitor threats. The insights from the other models reinforce the validity of this approach but highlight the need for tactical discipline and thorough legal preparation before taking overt action. First, regarding Company B, we will immediately proceed with the TPO. Because our physical teardown confirms they are utilizing public domain knowledge, we have a high-probability opportunity to narrow or invalidate their patent claims. This acts as a low-cost, high-impact preemptive strike, protecting our upcoming product launch from future infringement claims by Company B. Second, regarding Company C, we will not be deterred by their vague "prior rights" statement. The lack of a matching patent strongly suggests their claim is either a bluff or relies on unpatented trade secrets, neither of which can block our independent development. However, because our teardown indicates Company C is infringing on *our* patents, we hold significant leverage. Before initiating formal litigation, we will conduct a rigorous internal review, drafting detailed claim charts to solidify our infringement case. We will then send a structured response to Company C, demanding they clarify their claimed "prior rights" while simultaneously putting them on notice regarding their infringement of our intellectual property. This aggressive yet disciplined posture forces Company C to either back down or negotiate a favorable cross-licensing or non-assertion agreement from a position of weakness, clearing our path to market.

GPT-5.5

Answer: I would maintain the two-track plan: challenge Company B's patent with prior-art/public-domain evidence while separately investigating and asserting Company A's patents against Company C, using Company C's vague rights claim as a reason for diligence rather than as proof of an enforceable blocking right.

The other models broadly reinforce my original view rather than changing it. The strongest plan is neither to ignore Company B nor to overreact to Company C's public statement, but to manage both risks in parallel with litigation-ready discipline. For Company B, I would proceed promptly with the TPO using the best available prior art, including public-domain technical knowledge and any evidence that Company C's earlier product or disclosures predate Company B's filing. The teardown helps show that Company B is not using Company A's patented technology, but the TPO must focus on whether Company B's patent claims lack novelty or inventive step over what was already publicly known. The goal is to revoke, narrow, or create prosecution-history constraints around Company B's patent before Company A launches its own similar product. For Company C, I would not accept their statement about "prior rights" at face value. A claim to R&D results is not the same as an identified patent, and the failed patent search suggests their position may rest on trade secrets, pending unpublished applications, design rights, contractual rights, prior-user rights, or mere deterrent rhetoric. I would expand the search to related entities, inventors, foreign filings, unpublished-application watch periods, design registrations, and assignments, while documenting Company A's independent development to reduce trade-secret or copying allegations. At the same time, the teardown indicating that Company C likely infringes Company A's patents is a major leverage point. Before contacting them, I would have outside counsel prepare claim charts, test samples, preserve purchase records and teardown evidence, and evaluate validity, enforceability, damages, and business impact. If the infringement case is strong, Company A should approach Company C through counsel with a measured notice, request that Company C identify the specific rights it claims, and propose a license, cross-license, standstill, or non-assertion arrangement. If Company C refuses and the infringement is material, Company A should be ready to sue or seek appropriate injunctive and monetary relief. I would not necessarily freeze Company A's product launch until everything is resolved, as one model suggested, because that could give competitors a strategic veto. Instead, I would condition launch timing on a refreshed freedom-to-operate review, the likely scope of Company B's challenged claims, the seriousness of any rights Company C can actually identify, and the strength of Company A's infringement leverage against Company C.

Claude Opus 4.7

Answer: I am maintaining my position: file the TPO against Company B using the public domain prior art, force Company C to identify their alleged IP while preparing an infringement assertion against them, but I am refining the plan to incorporate broader prior-art searching and stricter pre-launch FTO discipline raised by other models.

The core strategic logic of my original answer holds up well against the other responses — every model converged on the same two-track approach: challenge B at the patent office while using C's likely infringement as offensive leverage against their vague 'prior rights' bluff. None of the other answers identified a flaw in that fundamental structure. However, GPT-5.5 raised two genuinely sharpening points I want to absorb without changing my overall position. First, the TPO's success depends on whether B's claims are novel/inventive over prior art, not merely on whether B is practicing public domain knowledge — those are related but distinct questions, and my prior-art dossier needs to be built around the claim language, not just the teardown. Second, the search for Company C's rights should be broadened to pending applications, foreign filings, design rights, prior-user rights, inventor/assignee searches, and related entities before I conclude their statement is pure bluff. This is good hygiene and reduces the risk of being blindsided by an unpublished application surfacing mid-dispute. Kimi K2.6's suggestion to delay product launch until the TPO resolves and a deal with C is finalized is prudent on risk but commercially expensive — TPOs can take a year or more. I would instead pursue an accelerated path: file the TPO, complete a full FTO including any newly discovered C rights, and design around B's claims as a parallel hedge so launch timing is not held hostage to the patent office. On Company C, I still reject the more cautious framing that we should treat their statement as potentially legitimate until proven otherwise. The asymmetry is clear: we have teardown evidence of likely infringement of our granted patents; they have a press release. The right move remains a counsel-drafted letter demanding they identify the specific IP, paired with a prepared infringement claim chart — opening with a cross-license offer (per Kimi/DeepSeek) is fine tactically, but only from a position where litigation is genuinely ready to file. Negotiating from strength requires the gun on the table to be loaded. So: same plan, tightened execution. attributedTo is null because no model changed my position; GPT-5.5 refined my methodology but did not alter the strategy.

DeepSeek V4 Pro

Answer: I will adapt my two-pronged strategy by accelerating the Company C infringement track using prepared claim charts and a clarifying demand letter, while maintaining the TPO against Company B’s patent as my primary blocking move, treating Company C’s statement as a likely unenforceable bluff until they disclose actual IP.

After reviewing the other responses, my core position remains largely unchanged—proceed with the TPO against Company B while leveraging Company C’s infringement—but I see room to sharpen the sequence and messaging. The analysis from GPT-5.5 and Claude Opus 4.7 reinforced that Company C’s public statement is almost certainly an intimidation tactic, not an enforceable right, given the absence of a matching patent. However, their emphasis on formally demanding clarification from Company C before escalating is a strategic refinement I will adopt: a pointed letter requiring Company C to identify any patent, application, or registered right they rely on shifts the burden to them, creates a record of potential bad faith, and buys time. For the Company B track, the TPO remains the highest priority. The teardown evidence of public domain use perfectly supports a prior art attack, and as Claude Opus 4.7 noted, the process is often anonymous and low-cost. I agree with GPT-5.5’s nuance that the key question for the TPO is the novelty of Company B’s claims over what was already known—not merely that Company B’s product itself uses public knowledge—so I will ensure the prior art dossier directly maps onto the patent’s claims. For Company C, the strategic pivot I’m making is to accelerate the patent assertion path without waiting for the TPO resolution. Kimi K2.6’s suggestion to use the infringement leverage for a non-assertion or cross-license before launch is compelling because it proactively removes legal uncertainty. However, I reject their recommendation to delay product launch until both the TPO and Company C deal are resolved; market timing is critical, and neither threat justifies a full hold—unless an injunction risk materializes, which is unlikely against Company C’s vague warning. In sum, I am maintaining my original position but refining it with (1) a formal demand letter to Company C before initiating licensing talks, (2) faster preparation of detailed infringement claim charts against Company C, and (3) continued legal groundwork so that if Company C fails to respond or escalates, I can quickly pivot to a declaratory judgment or offensive litigation. The goal remains the same: clear my launch path against Company B while turning the tables on Company C.

Kimi K2.6 (changed mind)

Answer: Company A should aggressively pursue the Third-Party Observation against Company B while demanding that Company C specify its claimed rights and preparing to enforce Company A's own patents against C, without delaying the product launch once a full freedom-to-operate review and independent-development documentation are completed.

The physical teardown confirming that Company B relies on public domain knowledge provides strong prior art for the TPO, and the broad roundtable consensus validates challenging B's patent as the highest-priority defensive move to clear our path to market. However, I am revising my previous recommendation to halt the product launch until the TPO is fully resolved and a deal with Company C is finalized. Claude Opus 4.7 persuasively argued that an indefinite delay is commercially damaging and unnecessary; instead, we should keep the launch on schedule while thoroughly documenting independent development and completing a comprehensive freedom-to-operate analysis to guard against trade-secret or undisclosed-rights claims. I also adopt Claude's tactical suggestion to send Company C a formal, measured response demanding that they identify the specific patents or other enforceable rights they claim. This forces C to either produce a patent number or expose their vague "prior rights" statement as a market-intimidation bluff, creating a critical evidentiary record. At the same time, I incorporate the diligence caution raised by GPT-5.5 to broaden our internal search to pending applications, foreign filings, and related entities so we do not dismiss C's threat prematurely. While C is pressed to disclose its rights, we should commission detailed infringement claim charts confirming that C's product violates our patents. With these charts in hand, we approach C privately to negotiate a cross-license or non-assertion agreement, using our enforcement leverage to neutralize their public posturing rather than waiting passively. This updated plan maintains my core two-track strategy but executes it with greater commercial speed, stronger defensive documentation, and more effective counter-leverage against Company C.

Final Summary

The AI Roundtable reached a unanimous final consensus on a dual-track strategy: filing a Third-Party Observation against Company B while aggressively countering Company C's vague 'prior rights' claims with infringement notices. All five models, led by Claude Opus 4.7 and GPT-5.5, concluded that Company C’s public statement is likely a bluff, as no patents were found. Kimi K2.6 initially suggested delaying the product launch but eventually aligned with the group, agreeing that Company A should proceed on schedule while using its own patent portfolio as leverage for a cross-licensing deal.

All 5 models agreed